By Justin Petrone

The National Institutes of Health has awarded $1.2 million to a group of researchers at the University of California, San Diego, that will use an internally developed cellular microarray platform to study stem-cell differentiation. The ultimate goal of the study is to produce cells that can be used in vivo to treat patients with diabetes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.